Lung Small Cell Carcinoma — Trials

Lung Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 381
Recruiting: 202
Ph III recruiting: 27
Growth YoY: −1%
Industry share: 43%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (157)

clinicaltrialsPublishedShowing 1–50 of 112 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07226999	Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer	recruiting	Phase 2 / Phase 3	550	PfizerINDUSTRY	10	Sep 28, 2026	clinicaltrials
NCT07476287	Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer	recruiting	Phase 2	40	PfizerINDUSTRY	12	Sep 28, 2026